Systems Thinking in Pharmaceutical Access: Futu...

By Rene Pretorius

March 26, 2025

As global healthcare systems grow more budget-focused, complex, and dynamic, pharma companies must evolve their value and access strategies accordingly. Systems-thinking-in...
Evolving Cervical Cancer Treatment: Innovations and Challenges
NICE Approves Gene Therapy for Sickle Cell: A Breakthrough in Treatment and H...
Cervical Cancer App: Enhancing Screening and Treatment
Surrogate Endpoints Guidance: New International Report Enhances HTA Practices
Cost-Effective Cervical Cancer Screening Strategies for Women with HIV in Kwa...
Cost-Effectiveness of Switching to the Nonavalent HPV Vaccine in the Netherlands
Reevaluating NICE’s Cost-Effectiveness Thresholds: The QALY Debate
Overview of NICE’s Elranatamab Managed Access Agreement
NICE Rejects Donanemab for NHS Use Due to Cost Concerns
UNAIDS Urges Greater Access for Gilead’s Lenacapavir
NICE Collaborates with Menarini to Evaluate Elacestrant Breast Cancer Treatment
Enhancing Child Mental Health Services with Digital Interventions